CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
A prospective study of FOLFOX4 regimen's tolerance in the treatment of metastatic colorectal cancer
DOI 10.1055/s-2005-869810
Bibliografische Angaben
Nachweis in CareLit
Autor:innenÉ Végh, Á Petrányi, K Tamas, Z Szűcs, G Bodoky
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: Oxaliplatin is an effective anticancer agent in the treatment of colorectal cancer (CRC), and its usage has become widespread also in Hungary in the last few years. Between February 2003 and January 2005. we evaluated the hematological, gastrointestinal, acute and chronic neurological and other type toxicities at our department, including the dose limiting toxicities of oxaliplatin plus de Gramont regimen.…
Zitieren
Zitierempfehlung
É Végh, Á Petrányi, K Tamas, Z Szűcs, G Bodoky (2005) A prospective study of FOLFOX4 regimen's tolerance in the treatment of metastatic colorectal cancer. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2005-869810
Mit CareLit weiterarbeiten